← All trials
NCT06518850
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2024
- Primary completion
- Dec 31, 2024
- Completion date
- Dec 31, 2025
- First posted
- Jul 24, 2024
- Last posted
- Jul 24, 2024
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chinese Academy of Medical SciencesLead sponsor
- Capital Medical UniversityCollaborator
- Capital Medical UniversityCollaborator
- Capital Medical UniversityCollaborator
- Capital Medical UniversityCollaborator
- Capital Medical UniversityCollaborator
- Air Force Military Medical University, ChinaCollaborator
- Chinese Academy of Medical SciencesOfficial
- Government of ChinaCollaborator
- Peking UniversityCollaborator
- Peking UniversityCollaborator
- Peking UniversityCollaborator
- Peking UniversityCollaborator
- Chinese Academy of Medical SciencesSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.